Eli Lilly's fast-growing blood cancer drug Jaypirca has bagged a new FDA approval as an earlier treatment for relapsed or refractory chronic lymphocytic leukaemia (CLL) or small lymphocytic lymphoma ...
To find SML’s beginnings, you have to go back to ETA, a cocktail bar in the Highland Park neighborhood of Los Angeles. The space opened in 2016, thanks to the work of James Bygrave, Ryan Julio, and ...
Pirtobrutinib, a highly selective, noncovalent Bruton’s tyrosine kinase inhibitor (BTKi), shows substantial improvements in progression-free survival over the chemotherapy regimen of bendamustine plus ...
In a new trial, the Bruton tyrosine kinase (BTK) inhibitor pirtobrutinib increased the rate of survival without disease progression and was well tolerated with a more favorable safety profile when ...
Please provide your email address to receive an email when new articles are posted on . Patients with CLL and SLL who received pirtobrutinib had superior response than those who received ibrutinib in ...
Pirtobrutinib, a non-covalent Bruton tyrosine kinase (BTK) inhibitor, met the primary endpoint for non-inferiority in terms of overall response rate in the first head-to-head comparison with ibrutinib ...
At a March Seattle gig, SML generated three epic improvisations of subtle groove science (the second piece even evoked the funky swagger of Average White Band’s “Schoolboy Crush”) and galvanic ...
Lisaftoclax achieved a 62.5% overall response rate and 23.89 months median progression-free survival in relapsed/refractory CLL/SLL patients. The study included high-risk patients, with 39% having del ...
Jaypirca, a non-covalent BTK inhibitor, is now approved for earlier use in CLL/SLL treatment, following prior covalent BTK inhibitor therapy. The expanded indication is based on the Bruin CLL-321 ...
A powerhouse quintet with deep ties to L.A.’s experimental music universe breaks jazz wide open on its second album, blurring the lines between live improv and post-production sorcery. Save this story ...
FountainVest and CPE have joined as new shareholders with the SML Group, a global leader in RFID and brand identification solutions, today announced that. The introduction of these two respected ...
The lawyer for Strategic Mobilization Ghana Limited (SML), Cephas Boyuo, has rejected the Office of the Special Prosecutor’s (OSP) allegations that the company’s founder, Evans Adusei, was used as a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback